vs
Side-by-side financial comparison of SAUL CENTERS, INC. (BFS) and Cytek Biosciences, Inc. (CTKB). Click either name above to swap in a different company.
SAUL CENTERS, INC. is the larger business by last-quarter revenue ($75.1M vs $62.1M, roughly 1.2× Cytek Biosciences, Inc.). SAUL CENTERS, INC. runs the higher net margin — 8.7% vs -70.9%, a 79.6% gap on every dollar of revenue. On growth, SAUL CENTERS, INC. posted the faster year-over-year revenue change (10.6% vs 8.1%). Over the past eight quarters, Cytek Biosciences, Inc.'s revenue compounded faster (17.7% CAGR vs 6.2%).
Saul Centers, Inc. is a self-administered real estate investment trust (REIT) headquartered in the United States. It primarily owns, operates, and develops high-quality shopping centers, mixed-use properties, and multifamily residential assets, with its core portfolio concentrated in the Washington D.C. metropolitan area and other select high-growth U.S. regional markets.
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
BFS vs CTKB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $75.1M | $62.1M |
| Net Profit | $6.5M | $-44.1M |
| Gross Margin | — | 52.9% |
| Operating Margin | 65.4% | -9.0% |
| Net Margin | 8.7% | -70.9% |
| Revenue YoY | 10.6% | 8.1% |
| Net Profit YoY | -19.6% | -557.1% |
| EPS (diluted) | $0.15 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $75.1M | $62.1M | ||
| Q3 25 | $72.0M | $52.3M | ||
| Q2 25 | $70.8M | $45.6M | ||
| Q1 25 | $71.9M | $41.5M | ||
| Q4 24 | $67.9M | $57.5M | ||
| Q3 24 | $67.3M | $51.5M | ||
| Q2 24 | $66.9M | $46.6M | ||
| Q1 24 | $66.7M | $44.9M |
| Q4 25 | $6.5M | $-44.1M | ||
| Q3 25 | $10.5M | $-5.5M | ||
| Q2 25 | $10.7M | $-5.6M | ||
| Q1 25 | $9.8M | $-11.4M | ||
| Q4 24 | $8.1M | $9.6M | ||
| Q3 24 | $14.5M | $941.0K | ||
| Q2 24 | $14.4M | $-10.4M | ||
| Q1 24 | $13.6M | $-6.2M |
| Q4 25 | — | 52.9% | ||
| Q3 25 | — | 52.7% | ||
| Q2 25 | — | 52.3% | ||
| Q1 25 | — | 48.6% | ||
| Q4 24 | — | 58.5% | ||
| Q3 24 | 73.6% | 56.3% | ||
| Q2 24 | 74.2% | 54.6% | ||
| Q1 24 | 72.8% | 51.3% |
| Q4 25 | 65.4% | -9.0% | ||
| Q3 25 | 69.1% | -17.6% | ||
| Q2 25 | 68.7% | -23.3% | ||
| Q1 25 | 66.5% | -36.1% | ||
| Q4 24 | 82.9% | 5.2% | ||
| Q3 24 | 72.8% | -8.2% | ||
| Q2 24 | 75.0% | -18.3% | ||
| Q1 24 | 72.4% | -23.9% |
| Q4 25 | 8.7% | -70.9% | ||
| Q3 25 | 14.6% | -10.5% | ||
| Q2 25 | 15.1% | -12.2% | ||
| Q1 25 | 13.6% | -27.5% | ||
| Q4 24 | 11.9% | 16.8% | ||
| Q3 24 | 21.5% | 1.8% | ||
| Q2 24 | 21.6% | -22.4% | ||
| Q1 24 | 20.4% | -13.8% |
| Q4 25 | $0.15 | — | ||
| Q3 25 | $0.32 | — | ||
| Q2 25 | $0.33 | — | ||
| Q1 25 | $0.29 | — | ||
| Q4 24 | $0.22 | — | ||
| Q3 24 | $0.48 | — | ||
| Q2 24 | $0.48 | — | ||
| Q1 24 | $0.45 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.7M | $90.9M |
| Total DebtLower is stronger | $468.4M | — |
| Stockholders' EquityBook value | $307.8M | $341.7M |
| Total Assets | $2.2B | $461.5M |
| Debt / EquityLower = less leverage | 1.52× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.7M | $90.9M | ||
| Q3 25 | $11.8M | $93.3M | ||
| Q2 25 | $5.3M | $75.5M | ||
| Q1 25 | $6.5M | $95.3M | ||
| Q4 24 | $10.3M | $98.7M | ||
| Q3 24 | $7.2M | $162.3M | ||
| Q2 24 | $6.9M | $177.9M | ||
| Q1 24 | $7.1M | $168.8M |
| Q4 25 | $468.4M | — | ||
| Q3 25 | $1.6B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $455.8M | — | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.4B | — |
| Q4 25 | $307.8M | $341.7M | ||
| Q3 25 | $316.6M | $378.6M | ||
| Q2 25 | $322.4M | $377.6M | ||
| Q1 25 | $328.4M | $379.6M | ||
| Q4 24 | $335.8M | $395.7M | ||
| Q3 24 | $341.8M | $385.5M | ||
| Q2 24 | $345.7M | $389.1M | ||
| Q1 24 | $347.1M | $392.6M |
| Q4 25 | $2.2B | $461.5M | ||
| Q3 25 | $2.2B | $494.9M | ||
| Q2 25 | $2.1B | $493.3M | ||
| Q1 25 | $2.1B | $482.6M | ||
| Q4 24 | $2.1B | $499.5M | ||
| Q3 24 | $2.1B | $491.2M | ||
| Q2 24 | $2.1B | $483.7M | ||
| Q1 24 | $2.0B | $492.1M |
| Q4 25 | 1.52× | — | ||
| Q3 25 | 5.02× | — | ||
| Q2 25 | 4.85× | — | ||
| Q1 25 | 4.70× | — | ||
| Q4 24 | 1.36× | — | ||
| Q3 24 | 4.37× | — | ||
| Q2 24 | 4.17× | — | ||
| Q1 24 | 4.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $99.8M | $-771.0K |
| Free Cash FlowOCF − Capex | — | $-1.8M |
| FCF MarginFCF / Revenue | — | -2.9% |
| Capex IntensityCapex / Revenue | — | 1.6% |
| Cash ConversionOCF / Net Profit | 15.35× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $99.8M | $-771.0K | ||
| Q3 25 | $20.6M | $-3.9M | ||
| Q2 25 | $26.6M | $108.0K | ||
| Q1 25 | $30.4M | $-125.0K | ||
| Q4 24 | $121.2M | $2.0M | ||
| Q3 24 | $26.5M | $13.2M | ||
| Q2 24 | $32.1M | $6.2M | ||
| Q1 24 | $33.8M | $4.0M |
| Q4 25 | — | $-1.8M | ||
| Q3 25 | — | $-4.6M | ||
| Q2 25 | — | $-1.5M | ||
| Q1 25 | — | $-974.0K | ||
| Q4 24 | — | $1.1M | ||
| Q3 24 | $-28.3M | $12.2M | ||
| Q2 24 | $-12.5M | $5.2M | ||
| Q1 24 | $-11.7M | $3.4M |
| Q4 25 | — | -2.9% | ||
| Q3 25 | — | -8.7% | ||
| Q2 25 | — | -3.2% | ||
| Q1 25 | — | -2.3% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | -42.1% | 23.7% | ||
| Q2 24 | -18.7% | 11.0% | ||
| Q1 24 | -17.6% | 7.6% |
| Q4 25 | — | 1.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | 81.5% | 2.0% | ||
| Q2 24 | 66.7% | 2.3% | ||
| Q1 24 | 68.3% | 1.3% |
| Q4 25 | 15.35× | — | ||
| Q3 25 | 1.97× | — | ||
| Q2 25 | 2.48× | — | ||
| Q1 25 | 3.10× | — | ||
| Q4 24 | 14.98× | 0.21× | ||
| Q3 24 | 1.83× | 14.05× | ||
| Q2 24 | 2.22× | — | ||
| Q1 24 | 2.48× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BFS
Segment breakdown not available.
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
